Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Humana Inc filings on SEC EDGAR ↗
Humana Inc. announced the pricing and results of its cash tender offers to repurchase up to $1.5 billion in aggregate purchase price of several series of its outstanding senior notes. The offers were part of a debt management strategy to retire various notes maturing between 2027 and 2032 using cash on hand.
Humana CLO Joseph C. Ventura Sells $2.38M of Stock
Joseph C. Ventura, CLO, sold 5,495 shares of Humana Inc at $433.85 a share, worth $2.38M in total on Nov 9, 2026. Shares held after the trade: 21,910 (-20.1%).
Humana Inc. has commenced cash tender offers to purchase up to $1.5 billion in aggregate purchase price of eight different series of its outstanding senior notes. The offers include various notes with maturities ranging from 2027 to 2032, subject to acceptance priority levels and a specific $800 million series cap for the 5.375% Senior Notes due 2031. This debt management transaction allows the company to retire existing higher-interest or near-term debt using available liquidity.
Humana Inc. reported total revenues of $41.16 billion for the third quarter of 2026, a significant increase from $32.65 billion in the prior year, though net income attributable to Humana decreased slightly to $162 million. The company's balance sheet remains robust with total assets growing to $57.29 billion, while cash flows from operating activities more than doubled to $5.38 billion for the nine months ended September 30, 2026.
Humana reported Q3 2026 financial results, including GAAP EPS of $1.33 and an adjusted loss per share of $0.70. The company raised its full-year 2026 adjusted EPS guidance to at least $9.50, up from the previous estimate of at least $9.00, citing favorable benefit ratios in its Insurance segment.